| UHC Commercial Medical & Drug | Gynecomastia Surgery – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Ilumya® (Tildrakizumab-Asmn) – Commercial Medical Benefit Drug Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Infertility Diagnosis, Treatment, and Fertility Preservation – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Leqvio® (Inclisiran) – Commercial Medical Benefit Drug Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Manipulative Therapy – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Negative Pressure Wound Therapy – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Ocular Photoscreening – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Omnibus Codes – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Pneumatic Compression Devices – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Prostate Surgeries and Interventions – Commercial and Individual Exchange Medical Policy | 2026-06-01 |